Literature DB >> 15862758

Long-term observation reveals time-course-dependent characteristics of tumour vascularisation.

Nils Hansen-Algenstaedt1, Claudia Joscheck, Christian Schaefer, Katrin Lamszus, Lars Wolfram, Tanja Biermann, Petra Algenstaedt, Marc A Brockmann, Carsten Heintz, Walter Fiedler, Wolfgang Rüther.   

Abstract

Functional properties of tumour vasculature influence the process of metastasis and play a role in generating a heterogeneous metabolic microenvironment, which contributes to genetic instability and inefficiency of tumour therapies. Morphological and functional properties of tumour vasculature may vary from tumour onset to late-stage disease. The aim of this study was to identify the dynamic alteration in tumour microcirculation in a chronic observation model. Invasively-growing, non-disseminating, green fluorescent protein transfected, human bone marrow derived endothelial cells, were implanted into cranial windows of severe combined immunodeficient mice. Intravital fluorescence microscopy was performed over a period of 85 days to measure permeability, leucocyte-endothelial interaction (LEI) and tissue perfusion rate as functional parameters. Vessel density, branching pattern and scanning electron microscopy were monitored as morphological parameters. Concordant with an increasing count of transendothelial pores, the results show that the initial event following tumour cell implantation was a significant increase in the permeability of pre-existing vessels. The variations in newly formed vessels were characterised by sequentially-occurring functional and morphological alterations with the development of characteristics typical of tumour vessels, such as increased count of trifurcations and variation in vessel calibre by more than 100%. In parallel with the increasing vessel volume per area, the tissue perfusion rate increased until day 61. It is concluded from the step-specific sequential functional and morphological alterations that the efficiency of adjuvant therapies depends not only on their intrinsic efficiency but also on the timing of their initiation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15862758     DOI: 10.1016/j.ejca.2004.12.034

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  7 in total

1.  Neural driven angiogenesis by overexpression of nerve growth factor.

Authors:  N Hansen-Algenstaedt; P Algenstaedt; C Schaefer; A Hamann; L Wolfram; G Cingöz; N Kilic; B Schwarzloh; M Schroeder; C Joscheck; L Wiesner; W Rüther; S Ergün
Journal:  Histochem Cell Biol       Date:  2005-11-29       Impact factor: 4.304

2.  Reduced glioma infiltration in Src-deficient mice.

Authors:  Caren V Lund; Mai T N Nguyen; Geoffrey C Owens; Andrew J Pakchoian; Ashkaun Shaterian; Carol A Kruse; Brian P Eliceiri
Journal:  J Neurooncol       Date:  2006-03-22       Impact factor: 4.130

3.  A novel high-resolution in vivo imaging technique to study the dynamic response of intracranial structures to tumor growth and therapeutics.

Authors:  Kelly Burrell; Sameer Agnihotri; Michael Leung; Ralph Dacosta; Richard Hill; Gelareh Zadeh
Journal:  J Vis Exp       Date:  2013-06-16       Impact factor: 1.355

4.  Feasibility and constraints of particle targeting using the antigen-antibody interaction.

Authors:  Viola Tokárová; Anna Pittermannová; Vlastimil Král; Pavlína Řezáčová; František Štěpánek
Journal:  Nanoscale       Date:  2013-10-29       Impact factor: 7.790

5.  In vivo functional and morphological characterization of bone and striated muscle microcirculation in NSG mice.

Authors:  Haider Mussawy; Lennart Viezens; Gerrit Hauenherm; Malte Schroeder; Christian Schaefer
Journal:  PLoS One       Date:  2017-08-11       Impact factor: 3.240

6.  The bone microenvironment promotes tumor growth and tissue perfusion compared with striated muscle in a preclinical model of prostate cancer in vivo.

Authors:  Haider Mussawy; Lennart Viezens; Malte Schroeder; Svenja Hettenhausen; Jördis Sündermann; Jasmin Wellbrock; Kai Kossow; Christian Schaefer
Journal:  BMC Cancer       Date:  2018-10-16       Impact factor: 4.430

7.  Non-invasive imaging for studying anti-angiogenic therapy effects.

Authors:  Josef Ehling; Twan Lammers; Fabian Kiessling
Journal:  Thromb Haemost       Date:  2013-02-14       Impact factor: 5.249

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.